AAAAAA

   
Results: 1-25 | 26-50 | 51-62 |
Results: 51-62/62
FACTORS TO CONSIDER IN SELECTING AN ANTIDEPRESSANT - CONCLUDING DISCUSSION
Authors: PRESKORN SH FEIGHNER JP CUNNINGHAM LA ROOSE SP BURKE MJ
Citation: Sh. Preskorn et al., FACTORS TO CONSIDER IN SELECTING AN ANTIDEPRESSANT - CONCLUDING DISCUSSION, The Journal of clinical psychiatry, 55, 1994, pp. 98-100
PRESKORN REPLIES
Authors: PRESKORN SH
Citation: Sh. Preskorn, PRESKORN REPLIES, The Journal of clinical psychiatry, 55(2), 1994, pp. 77-77
INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE
Authors: PRESKORN SH MAGNUS RD
Citation: Sh. Preskorn et Rd. Magnus, INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE, Psychopharmacology bulletin, 30(2), 1994, pp. 251-259
INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE
Authors: PRESKORN SH MAGNUS RD
Citation: Sh. Preskorn et Rd. Magnus, INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE, Psychopharmacology bulletin, 30(2), 1994, pp. 251-259
PHARMACOKINETICS IN CHILD ADOLESCENT PSYCHIATRIC-DISORDERS/
Authors: HUGHES CW PRESKORN SH
Citation: Cw. Hughes et Sh. Preskorn, PHARMACOKINETICS IN CHILD ADOLESCENT PSYCHIATRIC-DISORDERS/, Psychiatric annals, 24(2), 1994, pp. 76-82
THERAPEUTIC DRUG-MONITORING - PRINCIPLES AND PRACTICE
Authors: PRESKORN SH BURKE MJ FAST GA
Citation: Sh. Preskorn et al., THERAPEUTIC DRUG-MONITORING - PRINCIPLES AND PRACTICE, The Psychiatric clinics of North America, 16(3), 1993, pp. 611-645
PHARMACOKINETICS OF PSYCHOTROPIC AGENTS - WHY AND HOW THEY ARE RELEVANT TO TREATMENT - INTRODUCTION
Authors: PRESKORN SH
Citation: Sh. Preskorn, PHARMACOKINETICS OF PSYCHOTROPIC AGENTS - WHY AND HOW THEY ARE RELEVANT TO TREATMENT - INTRODUCTION, The Journal of clinical psychiatry, 54(9), 1993, pp. 3-7
PHARMACOKINETICS OF ANTIDEPRESSANTS - WHY AND HOW THEY ARE RELEVANT TO TREATMENT
Authors: PRESKORN SH
Citation: Sh. Preskorn, PHARMACOKINETICS OF ANTIDEPRESSANTS - WHY AND HOW THEY ARE RELEVANT TO TREATMENT, The Journal of clinical psychiatry, 54(9), 1993, pp. 14-34
MONITORING ANTIDEPRESSANT-INDUCED CEREBRAL HYPEREXCITABILITY - REPLY
Authors: PRESKORN SH
Citation: Sh. Preskorn, MONITORING ANTIDEPRESSANT-INDUCED CEREBRAL HYPEREXCITABILITY - REPLY, The Journal of clinical psychiatry, 54(5), 1993, pp. 201-202
SPECIAL AND INNOVATIVE USES OF BENZODIAZEPINES - INTRODUCTION AND RAISON-DETRE
Authors: MARTIN RL PRESKORN SH
Citation: Rl. Martin et Sh. Preskorn, SPECIAL AND INNOVATIVE USES OF BENZODIAZEPINES - INTRODUCTION AND RAISON-DETRE, Psychiatric annals, 23(6), 1993, pp. 299-300
THE ROLE OF BENZODIAZEPINES IN THE TREATMENT OF PSYCHOTIC DISORDERS
Authors: HORST WD PRESKORN SH
Citation: Wd. Horst et Sh. Preskorn, THE ROLE OF BENZODIAZEPINES IN THE TREATMENT OF PSYCHOTIC DISORDERS, Psychiatric annals, 23(6), 1993, pp. 317-324
RECENT PHARMACOLOGICAL ADVANCES IN ANTIDEPRESSANT THERAPY FOR THE ELDERLY
Authors: PRESKORN SH
Citation: Sh. Preskorn, RECENT PHARMACOLOGICAL ADVANCES IN ANTIDEPRESSANT THERAPY FOR THE ELDERLY, The American journal of medicine, 94, 1993, pp. 2-12
Risultati: 1-25 | 26-50 | 51-62 |